Table 3. Occurrence of the ‘turning point’ on the curve of HIV incidence at different levels of test-and-treat coverage.
| Occurrence of ‘turning point’ | HIV testing Rate | ART coverage | ART coverage by CD4 level | |
|---|---|---|---|---|
| CD4>350/uL | CD4≤350/uL | |||
| At the end of 2020 | 50% | 55% | 30% | 80% |
| 55% | 53% | 25% | 80% | |
| 60% | 50% | 20% | 80% | |
| 65% | 48% | 15% | 80% | |
| 70% | 45% | 10% | 80% | |
| At the end of 2015 | 50% | 58% | 35% | 80% |
| 55% | 55% | 30% | 80% | |
| 60% | 53% | 25% | 80% | |
| 65% | 50% | 20% | 80% | |
| 70% | 48% | 15% | 80% | |
| At the end of 2013 | 50% | 60% | 40% | 80% |
| 55% | 58% | 35% | 80% | |
| 60% | 55% | 30% | 80% | |
| 65% | 53% | 25% | 80% | |
| 70% | 50% | 20% | 80% | |
Note: We assume that the test-and-treat policy is started from the beginning of 2013.